Browsing Wolfson Institute of Preventive Medicine by Author "Lockley, M"
Now showing items 1-8 of 8
-
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2
Philpott, S; Raikou, M; Manchanda, R; Lockley, M; Singh, N; Scott, M; Evans, DG; Adlard, J; Ahmed, M; Edmondson, R (2023) -
The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma
Cheng, Z; Mirza, H; Ennis, DP; Smith, P; Gavarro, LM; Sokota, C; Giannone, G; Goranova, T; Bradley, T; Piskorz, A (2022) -
Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study.
Chandrasekaran, D; Sobocan, M; Blyuss, O; Miller, RE; Evans, O; Crusz, SM; Mills-Baldock, T; Sun, L; Hammond, RFL; Gaba, F (MDPI, 2021-08-27)We present findings of a cancer multidisciplinary-team (MDT) coordinated mainstreaming pathway of unselected 5-panel germline BRCA1/BRCA2/RAD51C/RAD51D/BRIP1 and parallel somatic BRCA1/BRCA2 testing in all women with ... -
Pathological Chemotherapy Response Score Predicts Survival in Patients with Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis of Individual Patient Data
Cohen, P; Powell, A; Böhm, S; Gilks, CB; Stewart, CJR; Meniawy, TM; Bulsara, M; Avril, S; Brockbank, EC; Bosse, T (2018-07-11) -
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study.
Sobocan, M; Chandrasekaran, D; Sideris, M; Blyuss, O; Fierheller, C; Kalra, A; Sia, J; Miller, RE; Mills-Baldock, T; Crusz, SM (Wiley, 2023-09-26)OBJECTIVE: To evaluate patient preference for short (gist) or detailed/extensive decision aids (DA) for genetic testing at ovarian cancer (OC) diagnosis. DESIGN: Cohort study set within recruitment to the Systematic Genetic ... -
RESULTS OF THE AVOIDING LATE DIAGNOSIS OF OVARIAN CANCER (ALDO) PROJECT; A PILOT NATIONAL SURVEILLANCE PROGRAM FOR BRCA MUTATION-CARRIERS
Philpott, S; Raikou, M; Manchanda, R; Evans, G; Edmondson, R; Menon, U; Ahmed, M; Woodward, E; Lamnisos, A; Lockley, M (2021) -
Role of Ki67 Proliferation Index and CD8 Tumour-Infitrating Lymphocyte Counts in Predicting Outcome in High-Grade Serous Tubo-Ovarian Carcinoma (HGSC) Showing No/Partial Response to Neoadjuvant Chemotherapy
Casey, L; Powell, A; Bohm, S; Manchanda, R; Lockley, M; Kobel, M; Singh, N (2020) -
Role of Ki67 Proliferation Index and CD8 Tumour-Infitrating Lymphocyte Counts in Predicting Outcome in High-Grade Serous Tubo-Ovarian Carcinoma (HGSC) Showing No/Partial Response to Neoadjuvant Chemotherapy
Casey, L; Powell, A; Bohm, S; Manchanda, R; Lockley, M; Kobel, M; Singh, N (2020)